Immunotherapy for multiple myeloma: new chances and hope

被引:0
|
作者
Jingyu Xu [1 ,2 ]
Gang An [1 ,2 ]
Lugui Qiu [1 ,2 ]
机构
[1] State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College
[2] Tianjin Institutes of Health Science
基金
中国国家自然科学基金;
关键词
D O I
暂无
中图分类号
R733.3 [骨髓肿瘤];
学科分类号
100214 ;
摘要
Introduction Multiple myeloma(MM), characterized by the proliferation of monoclonal plasma cells in the bone marrow, has the second highest incidence among hematologic malignancies1. Because of its incurable nature, treatments for MM are aimed primarily at obtaining minimal residual disease(MRD) negativity and achieving persistent control, both of which are believed to be important strategies to prolong survival and improve prognosis in patients with MM.
引用
收藏
页码:695 / 700
页数:6
相关论文
共 50 条
  • [21] Investigational agents in immunotherapy: a new horizon for the treatment of multiple myeloma
    Varga, Cindy
    Laubach, Jacob P.
    Anderson, Kenneth C.
    Richardson, Paul G.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 (04) : 433 - 446
  • [22] Immunotherapy: A New Approach to Treating Multiple Myeloma with Daratumumab and Elotuzumab
    Afifi, Salma
    Michael, Angela
    Lesokhin, Alexander
    ANNALS OF PHARMACOTHERAPY, 2016, 50 (07) : 555 - 568
  • [23] Promising Antigens for the New Frontier of Targeted Immunotherapy in Multiple Myeloma
    Cho, Shih-Feng
    Xing, Lijie
    Anderson, Kenneth C.
    Tai, Yu-Tzu
    CANCERS, 2021, 13 (23)
  • [24] DC in multiple myeloma immunotherapy
    Turtle, CJ
    Brown, RD
    Joshua, DE
    Hart, DNJ
    CYTOTHERAPY, 2004, 6 (02) : 128 - 137
  • [25] Cellular immunotherapy for multiple myeloma
    Rosenblatt, Jacalyn
    Avigan, David
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2008, 21 (03) : 559 - 577
  • [26] Strategies for immunotherapy in multiple myeloma
    Klein, B
    HEMATOLOGY AND CELL THERAPY, 1998, 40 (02): : 90 - 91
  • [27] Immunopathogenesis and immunotherapy of multiple myeloma
    Hideto Tamura
    International Journal of Hematology, 2018, 107 : 278 - 285
  • [28] IMMUNOTHERAPY OF MULTIPLE-MYELOMA
    HUANG, YW
    VITETTA, ES
    STEM CELLS, 1995, 13 (02) : 123 - 134
  • [29] The Role of Immunotherapy in Multiple Myeloma
    Kocoglu, Mehmet
    Badros, Ashraf
    PHARMACEUTICALS, 2016, 9 (01)
  • [30] Editorial: Immunotherapy in Multiple Myeloma
    Giuliani, Nicola
    Malavasi, Fabio
    FRONTIERS IN IMMUNOLOGY, 2019, 10